Filana Therapeutics, Inc. FLNA
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -10.73M | -8.60M | -10.33M | -12.54M | -10.81M |
| Total Depreciation and Amortization | 210.00K | 244.00K | 243.00K | 367.00K | 131.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.48M | 4.07M | 4.07M | 5.37M | 4.40M |
| Change in Net Operating Assets | 946.00K | 433.00K | -2.86M | -2.95M | 53.00K |
| Cash from Operations | -6.09M | -3.86M | -8.88M | -9.75M | -6.22M |
| Capital Expenditure | -31.00K | -21.00K | -- | -501.00K | -80.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -31.00K | -21.00K | -- | -501.00K | -80.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1.62M | -- | -- | 0.00 | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 67.00K | -16.00K | -51.00K | -329.00K | -- |
| Cash from Financing | 1.68M | -16.00K | -51.00K | -329.00K | 0.00 |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -4.44M | -3.89M | -8.93M | -10.58M | -6.30M |